Healthy Patients
Antimicrobial resistance (AMR)
AMR develops when bacteria, fungi or viruses are exposed to antibiotics, antifungals or antivirals. As a result, the antimicrobials become ineffective and infections may persist. In addition, medical interventions including surgery, chemotherapy and stem cell therapy may become impossible.
AMR is considered the biggest global threat of Health and Food Safety.
AMR Insights
For Healthcare professionals who wish to prevent Antimicrobial resistance, AMR Insights offers selected, global information and data, specific education and extensive networking and partnering opportunities.
AMR Insights is for:
- Medical Microbiologists, Infectiologists and other specialists
- General Practitioners, Pharmacists
- Infection Prevention Experts and nurses
- Medical Docters and Caretakers in nursing homes
- Managers and Labtechnicians of Microbiological Laboratories.
Latest Topics
-
28 August 2025PAHO calls for strengthened vaccination and surveillance amid the spread of antibiotic-resistant pertussis in the Americas
The Pan American Health Organization (PAHO) has raised alarm over a sharp resurgence of pertussis (whooping cough) in the Americas and the rise of antibiotic-resistant Bordetella pertussis strains. Reported cases surged from 4,139 in 2023 to 43,751 in 2024, with nearly 19,000 cases and 128 deaths already in the first seven months of 2025. Key […]
Read more... -
25 August 2025A layered strategy for tackling antimicrobial resistance: the Swiss cheese model for policy, prevention, and engagement
The article introduces a Swiss cheese model applied to antimicrobial resistance (AMR). This model illustrates that while individual layers of defense against AMR have flaws (“holes”), aligning multiple imperfect layers reduces overall risk of failure. (ICARS) Proposed strategy: The authors propose 15 interdependent layers—spanning multiple sectors and interventions—that collectively form a robust, multitiered approach […]
Read more... -
18 August 2025A mixed methods evaluation of an antimicrobial prescribing clinical decision support system app
The study assessed the usability and accessibility of a digital antimicrobial prescribing app in a tertiary hospital, revealing common barriers such as navigation inefficiencies, technical barriers, limited onboarding, and concerns about clinical AI transparency. It highlighted the need for user-friendly CDSS tools and stakeholder co-design to improve medication safety.
Read more...
More news related to Healthy patients
